| Secondary |
| Diarrhoea |
10.1% |
| Meningitis |
10.1% |
| Muscle Abscess |
8.1% |
| Prophylaxis Against Diarrhoea |
8.1% |
| Short-bowel Syndrome |
8.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
6.1% |
| Chronic Myeloid Leukaemia |
4.7% |
| Gastric Ulcer |
4.7% |
| Analgesic Therapy |
4.1% |
| Antipyresis |
4.1% |
| Convulsion |
4.1% |
| Insomnia |
4.1% |
| Osteoporosis |
4.1% |
| Asthma |
3.4% |
| Crohn's Disease |
2.7% |
| Infection |
2.7% |
| Product Used For Unknown Indication |
2.7% |
| Prophylaxis |
2.7% |
| Psoas Abscess |
2.7% |
| Systemic Candida |
2.7% |
|
| Toxic Epidermal Necrolysis |
37.5% |
| White Blood Cell Count Decreased |
25.0% |
| Abdominal Distension |
12.5% |
| Diarrhoea |
6.3% |
| Hyperuricaemia |
6.3% |
| Hypocalcaemia |
6.3% |
| Hypomagnesaemia |
6.3% |
|
| Concomitant |
| Crohn's Disease |
18.2% |
| Product Used For Unknown Indication |
14.1% |
| Diarrhoea |
11.4% |
| Drug Use For Unknown Indication |
8.9% |
| Prophylaxis |
8.0% |
| Multiple Myeloma |
5.6% |
| Hypertension |
4.5% |
| Gastritis |
3.7% |
| Colitis Ulcerative |
3.4% |
| Ascites |
2.5% |
| Constipation |
2.4% |
| Prophylaxis Against Diarrhoea |
2.2% |
| Hepatic Cirrhosis |
2.1% |
| Supportive Care |
2.1% |
| Asthma |
1.9% |
| Castleman's Disease |
1.9% |
| Insomnia |
1.9% |
| Administration Related Reaction |
1.8% |
| Cerebral Palsy |
1.8% |
| Hepatic Neoplasm Malignant |
1.8% |
|
| White Blood Cell Count Decreased |
11.1% |
| Ascites |
7.9% |
| Pneumonia |
7.9% |
| Administration Related Reaction |
7.1% |
| Cytomegalovirus Infection |
6.3% |
| Pyrexia |
6.3% |
| Vomiting |
6.3% |
| Pleural Effusion |
5.6% |
| Renal Failure Acute |
4.8% |
| Melaena |
4.0% |
| Pneumothorax |
4.0% |
| Drug Eruption |
3.2% |
| Hepatic Failure |
3.2% |
| Hypokalaemia |
3.2% |
| Idiopathic Thrombocytopenic Purpura |
3.2% |
| Intestinal Obstruction |
3.2% |
| Nausea |
3.2% |
| Neutrophil Count Decreased |
3.2% |
| Pain In Extremity |
3.2% |
| Thrombocytopenia |
3.2% |
|
| Interacting |
| Upper Respiratory Tract Inflammation |
37.5% |
| Borderline Personality Disorder |
25.0% |
| Product Used For Unknown Indication |
25.0% |
| Behcet's Syndrome |
12.5% |
|
|
